199 related articles for article (PubMed ID: 31842489)
1. Somatic Mutation of
Lee KH; Hwang HJ; Noh HJ; Shin TJ; Cho JY
Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31842489
[TBL] [Abstract][Full Text] [Related]
2. Whole exome sequencing identifies novel variants of PIK3CA and validation of hotspot mutation by droplet digital PCR in breast cancer among Indian population.
Kumar R; Kumar R; Goel H; Kumar S; Ningombam SS; Haider I; Agrawal U; Deo S; Gogia A; Batra A; Sharma A; Mathur S; Ranjan A; Chopra A; Hussain S; Tanwar P
Cancer Cell Int; 2023 Oct; 23(1):236. PubMed ID: 37821962
[TBL] [Abstract][Full Text] [Related]
3. PIK3CA is recurrently mutated in canine mammary tumors, similarly to in human mammary neoplasia.
Arendt ML; Sakthikumar S; Melin M; Elvers I; Rivera P; Larsen M; Saellström S; Lingaas F; Rönnberg H; Lindblad-Toh K
Sci Rep; 2023 Jan; 13(1):632. PubMed ID: 36635367
[TBL] [Abstract][Full Text] [Related]
4. Anticancer effects of alpelisib on PIK3CA-mutated canine mammary tumor cell lines.
Yeom J; Cho Y; Ahn S; Jeung S
Front Vet Sci; 2023; 10():1279535. PubMed ID: 38033642
[TBL] [Abstract][Full Text] [Related]
5. Alternative methylation of intron motifs is associated with cancer-related gene expression in both canine mammary tumor and human breast cancer.
Nam AR; Lee KH; Hwang HJ; Schabort JJ; An JH; Won SH; Cho JY
Clin Epigenetics; 2020 Jul; 12(1):110. PubMed ID: 32693820
[TBL] [Abstract][Full Text] [Related]
6. Cooperation between Pik3ca and p53 mutations in mouse mammary tumor formation.
Adams JR; Xu K; Liu JC; Agamez NM; Loch AJ; Wong RG; Wang W; Wright KL; Lane TF; Zacksenhaus E; Egan SE
Cancer Res; 2011 Apr; 71(7):2706-17. PubMed ID: 21324922
[TBL] [Abstract][Full Text] [Related]
7. Physiological levels of Pik3ca(H1047R) mutation in the mouse mammary gland results in ductal hyperplasia and formation of ERα-positive tumors.
Tikoo A; Roh V; Montgomery KG; Ivetac I; Waring P; Pelzer R; Hare L; Shackleton M; Humbert P; Phillips WA
PLoS One; 2012; 7(5):e36924. PubMed ID: 22666336
[TBL] [Abstract][Full Text] [Related]
8. Mutational hotspot in exon 20 of PIK3CA in breast cancer among Singapore Chinese.
Liang X; Lau QC; Salto-Tellez M; Putti TC; Loh M; Sukumar S
Cancer Biol Ther; 2006 May; 5(5):544-8. PubMed ID: 16582596
[TBL] [Abstract][Full Text] [Related]
9. Cross-species oncogenic signatures of breast cancer in canine mammary tumors.
Kim TM; Yang IS; Seung BJ; Lee S; Kim D; Ha YJ; Seo MK; Kim KK; Kim HS; Cheong JH; Sur JH; Nam H; Kim S
Nat Commun; 2020 Jul; 11(1):3616. PubMed ID: 32680987
[TBL] [Abstract][Full Text] [Related]
10. Current biomarkers of canine mammary tumors.
Kaszak I; Ruszczak A; Kanafa S; Kacprzak K; Król M; Jurka P
Acta Vet Scand; 2018 Oct; 60(1):66. PubMed ID: 30373614
[TBL] [Abstract][Full Text] [Related]
11. PIK3CA mutations matter for cancer in dogs.
Kim JH
Res Vet Sci; 2020 Dec; 133():39-41. PubMed ID: 32932196
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation of PI3K/Akt/PTEN Pathway in Canine Mammary Tumor.
Kim SH; Seung BJ; Cho SH; Lim HY; Bae MK; Sur JH
Animals (Basel); 2021 Jul; 11(7):. PubMed ID: 34359206
[TBL] [Abstract][Full Text] [Related]
13. Canine mammary tumors as a model for human disease.
Abdelmegeed SM; Mohammed S
Oncol Lett; 2018 Jun; 15(6):8195-8205. PubMed ID: 29928319
[TBL] [Abstract][Full Text] [Related]
14. A living biobank of canine mammary tumor organoids as a comparative model for human breast cancer.
Inglebert M; Dettwiler M; Hahn K; Letko A; Drogemuller C; Doench J; Brown A; Memari Y; Davies HR; Degasperi A; Nik-Zainal S; Rottenberg S
Sci Rep; 2022 Oct; 12(1):18051. PubMed ID: 36302863
[TBL] [Abstract][Full Text] [Related]
15. Establishment of a New Cell Line of Canine Mammary Tumor CMT-1026.
Mei C; Xin L; Liu Y; Lin J; Xian H; Zhang X; Hu W; Xia Z; Wang H; Lyu Y
Front Vet Sci; 2021; 8():744032. PubMed ID: 34712723
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of STAT3, β-catenin, and IGF-1R sensitize mouse PIK3CA-mutant breast cancer to PI3K inhibitors.
Merino VF; Cho S; Liang X; Park S; Jin K; Chen Q; Pan D; Zahnow CA; Rein AR; Sukumar S
Mol Oncol; 2017 May; 11(5):552-566. PubMed ID: 28296140
[TBL] [Abstract][Full Text] [Related]
17. Profiling canine mammary tumors: A potential model for studying human breast cancer.
Gherman LM; Chiroi P; Nuţu A; Bica C; Berindan-Neagoe I
Vet J; 2024 Feb; 303():106055. PubMed ID: 38097103
[TBL] [Abstract][Full Text] [Related]
18. Reactivation of multipotency by oncogenic PIK3CA induces breast tumour heterogeneity.
Van Keymeulen A; Lee MY; Ousset M; Brohée S; Rorive S; Giraddi RR; Wuidart A; Bouvencourt G; Dubois C; Salmon I; Sotiriou C; Phillips WA; Blanpain C
Nature; 2015 Sep; 525(7567):119-23. PubMed ID: 26266985
[TBL] [Abstract][Full Text] [Related]
19.
Schabort JJ; Nam AR; Lee KH; Kim SW; Lee JE; Cho JY
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33218035
[TBL] [Abstract][Full Text] [Related]
20. Association of
Tjader NP; Beer AJ; Ramroop J; Tai MC; Ping J; Gandhi T; Dauch C; Neuhausen SL; Ziv E; Sotelo N; Ghanekar S; Meadows O; Paredes M; Gillespie J; Aeilts A; Hampel H; Zheng W; Jia G; Hu Q; Wei L; Liu S; Ambrosone CB; Palmer JR; Carpten JD; Yao S; Stevens P; Ho WK; Pan JW; Fadda P; Huo D; Teo SH; McElroy JP; Toland AE
medRxiv; 2023 Dec; ():. PubMed ID: 38106140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
